Evidence map›Paper›PMID 34203143›Full record

ReviewInternational journal of molecular sciences2021

Brain Mechanisms of COVID-19-Sleep Disorders.

Oxana Semyachkina-Glushkovskaya, Aysel Mamedova, Valeria Vinnik, Maria Klimova, Elena Saranceva, Vasily Ageev, Tingting Yu, Dan Zhu, Thomas Penzel, Jürgen Kurths

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. COVID-19 infection and sleep health: findings from the nationally representative COVID-19's Unequal Racial Burden survey.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. The Clinical Observation of Inflammation Theory for Depression: The Initiative of the Formosa Long COVID Multicenter Study (FOCuS).Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Oxana Semyachkina-GlushkovskayaInstitute of Physics, Humboldt University, Newtonstrasse 15, 12489 Berlin, Germany.ORCID 0000-0001-6753-7513
Aysel MamedovaDepartment of Biology, Saratov State University, Atrakhanskaya Str. 83, 410012 Saratov, Russia.
Valeria VinnikDepartment of Biology, Saratov State University, Atrakhanskaya Str. 83, 410012 Saratov, Russia.
Maria KlimovaDepartment of Biology, Saratov State University, Atrakhanskaya Str. 83, 410012 Saratov, Russia.
Elena SarancevaDepartment of Biology, Saratov State University, Atrakhanskaya Str. 83, 410012 Saratov, Russia.
Vasily AgeevDepartment of Biology, Saratov State University, Atrakhanskaya Str. 83, 410012 Saratov, Russia.
Tingting YuWuhan National Laboratory for Optoelectronics, Britton Chance Center for Biomedical Photonics, Huazhong University of Science and Technology, Wuhan 430074, China.
Dan ZhuWuhan National Laboratory for Optoelectronics, Britton Chance Center for Biomedical Photonics, Huazhong University of Science and Technology, Wuhan 430074, China.
Thomas PenzelDepartment of Biology, Saratov State University, Atrakhanskaya Str. 83, 410012 Saratov, Russia.ORCID 0000-0002-4304-0112
Jürgen KurthsInstitute of Physics, Humboldt University, Newtonstrasse 15, 12489 Berlin, Germany.
Saratov State University · RUWuhan National Laboratory for Optoelectronics · CN

Funding

Foundation for Innovative Research Groups of the National Natural Science Foundation of China 81961138015, 61860206009Ministry of Science and Higher Education of the Russian Federation 075-15-2019-1885Russian Foundation for Basic Research 19-515-55016, 20-015-00308-aRussian Science Foundation 20-15-00090, 18-75-10033
6 · The paper itself

Abstract

2020 and 2021 have been unprecedented years due to the rapid spread of the modified severe acute respiratory syndrome coronavirus around the world. The coronavirus disease 2019 (COVID-19) causes atypical infiltrated pneumonia with many neurological symptoms, and major sleep changes. The exposure of people to stress, such as social confinement and changes in daily routines, is accompanied by various sleep disturbances, known as 'coronasomnia' phenomenon. Sleep disorders induce neuroinflammation, which promotes the blood-brain barrier (BBB) disruption and entry of antigens and inflammatory factors into the brain. Here, we review findings and trends in sleep research in 2020-2021, demonstrating how COVID-19 and sleep disorders can induce BBB leakage via neuroinflammation, which might contribute to the 'coronasomnia' phenomenon. The new studies suggest that the control of sleep hygiene and quality should be incorporated into the rehabilitation of COVID-19 patients. We also discuss perspective strategies for the prevention of COVID-19-related BBB disorders. We demonstrate that sleep might be a novel biomarker of BBB leakage, and the analysis of sleep EEG patterns can be a breakthrough non-invasive technology for diagnosis of the COVID-19-caused BBB disruption.

Indexed as

Blood-Brain BarrierBrainCircadian RhythmCOVID-19CytokinesHumansSARS-CoV-2Sleep Wake DisordersCytokinesbrain mechanismsCOVID-19-sleep disordersthe blood–brain barrier permeability

Identifiers

PMID34203143
PMCPMC8268116
OpenAlexW3177108658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.